NEW YORK (GenomeWeb News) – GnuBio today said that it has completed a $10 million Series B round of financing with private investors.

The Cambridge, Mass.-based firm didn't disclose the names of the investors but said that the round included investors from its Series A round. GnuBio completed that $8 million Series A round a year ago, and it also declined to disclose the names of the investors at that time.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

David Dobbs writes at Buzzfeed that genomics has delivered little on its promises.

In PNAS this week: co-evolutionary signatures of insect hosts and bacterial symbionts, distinct transcript isoforms of high-grade ovarian cancer, and more.

Adam Rutherford discusses genetic genealogy at the Guardian.

Portions of the US 21st Century Cures Act are raising some safety concerns.